| CAS ID: | 1307293-62-4 |
| Molecular Formula: | C22H39N9O11S |
| Molecular Weight: | 637.7 g/mol |
| Monoisotopic Mass: | 637.249 g/mol |
| Class: | Peptide |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H39N9O11S/c1-11(32)17(20(37)31-7-3-5-14(31)21(38)39)30-19(36)13(10-43(40,41)42)29-16(34)9-27-18(35)12(28-15(33)8-23)4-2-6-26-22(24)25/h11-14,17,32H,2-10,23H2,1H3,(H,27,35)(H,28,33)(H,29,34)(H,30,36)(H,38,39)(H4,24,25,26)(H,40,41,42)/t11-,12+,13+,14+,17+/m1/s1 | See All |
| InChI Key: | MYZAXBZLEILEBR-RVFOSREFSA-N | |
| Smiles: | CC(C(C(=O)N1CCCC1C(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)CN)O | See All |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT02153476 | Disease | Scar |
| Phase | Phase 2 | Status | Completed |
| First Received | June 3, 2014 | Last Verified | December 18, 2018 |
| Sponsor | Allegro Ophthalmics, LLC | ||
| PubChem: | 130476723 |
| ChEMBL: |